BioSpace News Archive

The Privately Owned ER Alternative is Staffed by ER Doctors and Offers Patients More On-Site Medical Services Than Most Urgent Care Centers

TheAnswerPage.com has launched a newly redesigned website, powered by Scitent, and a Comprehensive Medical Marijuana Curriculum which features new CME/CE accredited content focused on the endocannabinoid system and medical marijuana.

Cara Therapeutics, Inc. (Nasdaq:CARA), today announced positive topline data from the KALM-1 pivotal Phase 3 trial of KORSUVA™ (CR845/difelikefalin) Injection in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP)

CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research — has unveiled a six-episode discussion series featuring Laura O’Brien, who shares her journey through stage 3 non-small cell lung cancer (NSCLC) and immunotherapy with Dr. Jyoti D. Patel.

HQP will provide services to three southern California counties with a targeted outreach to four ethnic population groups and three targeted languages

Blueprint Medicines Corporation announced its participation in the following upcoming investor conferences

Amgen (NASDAQ: AMGN) will host a webcast investor meeting at ASCO 2019 on Monday, June 3 at 6:30 p.m.

Audentes Therapeutics, Inc. (Nasdaq: BOLD), today announced that it has appointed Edward R. Conner, M.D. as Senior Vice President and Chief Medical Officer and promoted Fulvio Mavilio, Ph.D. to Senior Vice President of Translational Science.

Study Proves Alpha-Stim Treatment is As Effective and More Cost Efficient Than Current First-Line Therapy

Heron Therapeutics, Inc. (Nasdaq: HRTX), today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 3:00 p.m. EDT in New York, NY.